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We report a 38-year-old woman with a left lung tumor presenting as obstructive pneumonia. Bron-
choscopic examination revealed a polypoid tumor ﬁlling the left main bronchus. The tumor was partially
resected by a snaring procedure for diagnostic purposes. Microscopic examination revealed a submucosal
tumor located underneath normal bronchial epithelium. The tumor was composed of sheets of uniform
oval to cuboidal cells encompassing numerous blood vessels. Immunohistochemically, the tumor cells
exhibited smooth muscle markers, but were negative for neuroendocrine markers. The diagnosis of
primary pulmonary glomus tumor was therefore made. Subsequent bronchoscopic intervention allowed
us to pin-point the origin of the tumor: superior segmental B6a/b. She underwent a left lower lobe su-
perior segmental resection successfully. Glomus tumors are relatively rare soft tissue tumors, and those
of bronchopulmonary origin are exceedingly rare clinical condition. Among primary lung tumors, the
carcinoid tumor is a mimic of the glomus tumor, and differentiating these tumors is known to be difﬁcult,
especially using small biopsy samples. In the present case, a large tissue sample obtained by broncho-
scopic snaring was quite useful for the correct preoperative diagnosis. Because of the disease rarity,
malignancy grade estimation of visceral glomus tumors has not been clearly addressed. Recently, the
histopathological diagnostic criteria for malignant glomus tumors was deﬁned in the WHO classiﬁcation
of soft tissue and bone tumors 4th edition. Here we also reviewed the literature on primary broncho-
pulmonary glomus tumors with special attention to the current concept of malignancy grade estimation.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Glomus tumors are relatively rare soft tissue tumors composed
of cells that resemble the modiﬁed smooth muscle cells of the
specialized form of arteriovenous anastomosis “glomus body”
[1e4]. The most common site of the tumor is the subungual region;
however, they occasionally occur in visceral organs such as airway
tracts [1,2]. Primary glomus tumors of the lung are exceedingly rare,
and the diagnostic and therapeutic strategies for this rare condition
have not been well established. Here, we report a case of primary
pulmonary glomus tumor that arose in a left segmental bronchus aschiyo, Chiba 276-8524, Japan.
.
Ltd. This is an open access article ua protruding polypoid mass with a clinical manifestation of
obstructive pneumonia. In the present case, bronchoscopic inter-
vention became a powerful tool not only for histological diagnosis
but also for determining the proper operative procedure for the
tumor. Ever since the criteria for the diagnosis of malignancy in
glomus tumors was ﬁrst established in 2001 [5], the malignancy
estimation of visceral glomus tumors is a worrisome problem to be
addressed because of the rarity of this condition. Recently, the
criteria were modiﬁed and employed in the WHO classiﬁcation of
soft tissue and bone tumors 4th edition [4]. However, pulmonary
glomus tumors diagnosed by the current WHO criteria have been
scarcely reported. We also reviewed previous cases of primary
bronchopulmonary glomus tumors in the literature, with special
attention given to current diagnostic criteria.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A 38-year old woman visited a local hospital with the chief
complaint of high fever and was diagnosed with pneumonia. She
had no history of smoking. She had a past medical history of
bronchial asthma, but asthmatic symptoms had ceased for a long
time. Although antibiotic treatment was properly initiated, her
symptoms persisted. Chest CT examination revealed a left lower
lobe atelectasis with a water density mass in the left bronchus
(Fig. 1a). Bronchoscopic examination revealed a polypoid mass in
the left main bronchus. She was suspected of having a primary
bronchial tumor and was referred to our hospital for further ex-
amination. Physical examination revealed decreased air entry in
the left lower lung. Routine hematological and chemical laboratory
results were normal, except for a slight increase in CRP (1.0 mg/dl).
Upon initial bronchoscopic examination, a polypoid tumor was
observed that occluded nearly 90% of the lumen of the left main
bronchus (Fig. 1b). For conﬁrmation of the tumor type, a partial
resection of the tumor was performed by bronchoscopic snaring.
Postoperative chest X-ray revealed improvement of the atelectasis,
and she was tentatively discharged. The partially resected surgical
specimen consisted of tumor tissue that measured 1.5 cm inFig. 1. Radiological, endoscopic, and macroscopic ﬁndings. (a) Contrast-enhanced chest CT re
a white polypoid mass ﬁlling the left main bronchial lumen. (c, d) The tip of the endobronchi
smooth, and the cut-surface is tan in color. (eeg) Formalin-ﬁxed bronchopulmonary tissu
superior segmental B6a/b crista and enlarged the lumen of B6, B6a, and B6b.diameter (Fig. 1c). The tumor was well-circumscribed, ﬁrm, and tan
in color (Fig. 1d). Microscopically, the tumor was located within the
bronchial interstitial connective tissue covered by the bronchial
epithelium with focal erosion. The tumor was composed of sheets
of oval to cuboidal cells. Abundant vascular spaces were observed
in the tumor, and some were surrounded by tumor cells (Fig. 2a).
Blood vessels in the tumor were small to medium-sized, thin-
walled, and some were dilated, resembling capillaries or venules.
The tumor cells were uniformly monotonous with a centrally
placed round nucleus and amphophilic to lightly eosinophilic
cytoplasm (Fig. 2b). No necrosis, vascular invasion, obvious cellular
atypia, or mitotic ﬁgures were observed. Immunohistochemically,
the tumor cells exhibited cytoplasmic positivity for a-smooth
muscle actin, calponin, and vimentin (Fig. 2c and d). Immuno-
staining was negative for desmin. The individual tumor cells were
surrounded by positive staining for silver impregnation and anti-
type IV collagen antibody, which showed an intricate chicken-
wire pattern representing basement membrane material (Fig. 2e
and f). No immunoreactivity was found for cytokeratin, CD34, CD31,
S-100, CD56, chromogranin A, or synaptophysin (data not shown).
Ki-67 immunolabeling was detected in approximately 3% of tumor
cell nuclei. Histopathologically, the tumor was diagnosed as aveals a water density mass in the left main bronchus (arrows). (b) Bronchoscopy shows
al tumor partially resected by endoscopic snaring procedure. The surface of the tumor is
e obtained by left lower lobe segmental resection. A cylindrical mass arises from the
Fig. 2. Histological and immunohistochemical ﬁndings. (a) The tumor was composed of sheets of oval to cuboidal cells. Numerous vascular spaces are observed in the tumor.
Characteristically, tumor cells are constituents of the neoplastic vascular walls. H&E stain, original magniﬁcation x200. (b) The tumor cells are bland and uniformly monotonous
with a centrally placed round nucleus. There are no chromatin increment, obvious nucleoli, or mitotic ﬁgures. H&E stain, original magniﬁcation x400. (c) The tumor cells are
strongly immunoreactive for anti-a-smooth muscle actin antibody. Original magniﬁcation x200. (d) A portion of tumor cells are also immunoreactive for anti-calponin antibody.
Original magniﬁcation x200. (e) The individual tumor cell is surrounded by positive immunostaining for anti-type IV collagen antibody. Original magniﬁcation x400. (f) Silver
impregnation shows an intricate chicken-wire pattern between tumor cells, representing basement membrane material. Original magniﬁcation x400.
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our hospital because of total collapse of the left lung. A repeat
bronchoscopic examination revealed total obstruction of the left
main bronchus with bloody and ﬁbrinous coagulation. After
removal of the coagulative materials with biopsy forceps, the
bronchial tumor was resected by a snaring procedure. Then, the
origin of the tumor was conﬁned to the bronchial mucosa of the left
lower lobe superior segmental bronchus. One month later, she
underwent a left lower lobe superior segmental resection. Grossly,
the tumor was a ﬁrm cylindrical mass measuring 2.6 cm in length
and 1.4 cm in diameter, which arose from the superior segmental
B6a/b crista and ﬁlled and enlarged the lumen of B6, B6a, and B6b
(Fig. 1eeg). The proximal resection margin of the superior
segmental bronchus was free of tumor. Histopathological exami-
nation of the resected specimen conﬁrmed the preoperative diag-
nosis of a classical glomus tumor. In all sections, no necrosis,
inﬁltrative growth, vascular invasion, conspicuous cellular atypia,
increasedmitotic activity, or atypical mitotic ﬁgureswere observed.
The patient had an uneventful postoperative course. She had no
respiratory complaints and no recurrence of the tumor two years
following tumor resection, and then she was lost to follow-up.
3. Discussion
Glomus tumors are distinctive mesenchymal neoplasms
composed of cells that closely resemble the normal glomus body
[1e4]. Glomus tumors are uncommon, with an estimated incidence
of 1.6% in 500 consecutive soft tissue tumors [6]. The vast majority
of glomus tumors occur in the dermis and subcutis of the ex-
tremities, with the single most common site of the subungualregion of the ﬁnger; however, rare tumors have been reported in
visceral organs [1,2]. Primary glomus tumors of the lung are
exceedingly rare, with only 36 previously reported cases in the
English literature (Table 1) [5,7e36]. Almost the same number of
cases with primary tracheal glomus tumors have also been re-
ported to date [37]. A survey of the literature shows that the pri-
mary bronchopulmonary glomus tumor usually occurred in adults,
with the exception of a 9-year old female patient [5]. There is an
obvious male predominance (26 out of 37), in sharp contrast with a
striking female predominance (male to female ratio of 1:3) among
patients with subungual lesions [1,2]. No causative relationship has
yet been reported between smoking and tumorigenesis of glomus
tumors. Primary pulmonary glomus tumors affected both bronchi
and peripheral lung tissues including subpleural regions. In the
bronchus, the tumor appeared as protruding polypoid masses,
whereas it appeared as nodular lesions in the peripheral lung. The
sizes of pulmonary glomus tumors tend to be larger than those of
cutaneous glomus tumors with a typical tumor size of <1 cm [3,4].
Symptoms due to airway irritation and/or obstruction are common
in bronchial glomus tumors, whereas peripherally arising glomus
tumors are usually asymptomatic and found incidentally. The pre-
sent case is a central (bronchial) type of glomus tumor of the lung
presenting as pneumonia due to airway obstruction.
Histopathologically, there are two major diagnostic problems of
primary pulmonary glomus tumors: ﬁrst, the differential diagnosis
of glomus tumors from other pulmonary tumors, and the second is
the estimation of the malignant potential of this quite rare clini-
copathological condition. In general, the items of differential
diagnosis of cutaneal glomus tumors include adnexal tumors
(especially hidradenoma) and less frequently intradermal nevi
Table 1
Summary of reported cases of primary bronchopulmonary glomus tumors.
Ref. Age/
sex
Presenting
symptoms
Side Location Size
(cm)
Biopsy diagnosis Postoperative
histological
diagnosis
Metastasis; site Treatment Clinical
outcome
Classiﬁcation
according
to the WHO
3rd/4th ed.
[7] 67/M Epigastralgia L Lower lobe,
subpleural
6.5 N/A GT No Lobectomy FOD at 9
months
MGT/GTUMP
[8] 34/M ASX R Upper lobe 2.0 N/A GT No Lobectomy N/A GTUMP/
GTUMP
[9] 50/M ASX R Subpleural 1.1 Not performed GT No Wedge resection N/A GTUMP/
GTUMP
[9] 41/M ASX R Lower lobe,
peripheral
1.5 Not performed GT No Wedge resection FOD at 47
months
GTUMP/
GTUMP
[10] 20/M Pneumothorax L Main
bronchus
1.4 Carcinoid GT No Sleeve resection FOD at 9
months
GTUMP/
GTUMP
[10] 65/F ASX R Infrahilar 3.0 Not performed GT No Wedge resection FOD at 60
months
MGT/GTUMP
[10] 40/M ASX R Lower lobe,
subpleural
1.1 Hemangiopericytoma GT No Lobectomy FOD at 6
months
GTUMP/
GTUMP
[10] 69/M Hemoptysis R Upper lobe 9.5 Not performed Glomangiosarcoma Lung,
Mediastinum,
Brain, Liver, Skin
Lobectomy;
chemotherapy
DOD at 17
months
MGT/MGT
[5] 38/M N/A N/A Lung 3.8 N/A Glomangiosarcoma N/A N/A N/A MGT/MGT
[5] 9/F N/A N/A Lung 4.5 N/A Glomangiosarcoma GI tract N/A AWD at 60
months
MGTMGT
[11] 48/M Hemosputum L Main
bronchus
0.7 GT GT No Wedge resection FOD at 3
months
GTUMP/
GTUMP
[12] 29/F Cough,
dyspnea, chest
pain
L Main
bronchus
1.5 Carcinoid tumor GT No Bronchotomy plus
mass extirpation
FOD at 17
months
GTUMP/
GTUMP
[13] 53/M Cough R Basal
bronchus
2.5 Degenerated atypical
cells
Glomangiosarcoma No Lobectomy FOD at 23
months
MGT/MGT
[14] 29/M Chest
discomfort
R Main
bronchus
3.0 Adenoma GT of
undetermined
malignant
potential
No Sleeve upper
lobectomy with
node dissection
N/A MGT/GTUMP
[15] 40/M Fever, cough,
chest pain
R Main
bronchus
0.9 Not performed GT No Endoscopic
removal
FOD at 1
month
GTUMP/
GTUMP
[16] 50/M ASX R Upper lobe 4.0 N/A GT No Lobectomy N/A MGT/GTUMP
[17] 37/M Cough R Bronchus
intermedius
N/A GT Not obtained No Laser coagulation
followed by
cryotherapy
FOD at 3
months
N/D
[18] 67/M Cough R Superior
bronchial
trunk
0.8 Typical carcinoid GT No Segmental
resection
N/A GTUMP/
GTUMP
[19] 64/M ASX L Lower lobe 3.5 Not performed Glomangioma No Tumor removal N/A MGT/GTUMP
[20] 56/F Hemoptysis R Lower lobe 5.5 Not diagnostic Glomangiomyoma No Lobectomy N/A MGT/GTUMP
[21] 34/M Cough R Bronchus
intermedius
2.3 Typical carcinoid GT No Sleeve resection N/A MGT/GTUMP
[22] 55/M ASX R Upper lobe 1.1 N/A GT No Lobectomy N/A GTUMP/
GTUMP
[23] 69/M Hemoptysis R Main
bronchus
2.0 Angiomatous lesion GT No N/A N/A GTUMP/
GTUMP
[24] 21/F ASX L Upper lobe,
parahilar
2.5 N/A GT No Lobectomy N/A MGT/GTUMP
[25] 39/M Cough L Main
bronchus
2.5 GT GT No Endoscopic
resection
FOD at 72
months
MGT/GTUMP
[26] 74/M Cough,
dyspnea, chest
pain
R Upper lobe,
parahilar
3.4 GT Glomangiosarcoma No Lobectomy with
node dissection
FOD at 12
months
MGT/MGT
[27] late
30s/
M
Hemosputum R Bronchus
intermedius
1.5 Carcinoid, suspected GT No Sleeve lobectomy FOD at 10
months
GTUMP/
GTUMP
[28] 39/M ASX L Upper lobe N/A Neuroendocrine
tumor
Glomangioma No Lobectomy with
node dissection
FOD at 51
months
N/D
[29] 62/M Hemoptysis L Main
bronchus
1.6 GT GT No Sleeve lobectomy FOD at 30
months
GTUMP/
GTUMP
[30] 35/F Hemoptysis L Hilum N/A Glomangiosarcoma Glomangiosarcoma Lymph node,
Lung
Pneumonectomy
with node
dissection
N/A MGT/MGT
[31] 43/F ASX R Upper lobe,
peripheral
2.0 Sclerosing
hemangioma
GT No Thoracoscopic
lung resection
FOD at 6
months
GTUMP/
GTUMP
[32] 28/M Hyperpyrexia,
anemia
R Upper lobe 3.0 Not performed Low-grade MGT No Lobectomy FOD at 12
months
MGT/
Suspicion
of GTUMP
[33] 60/F L 2.5 MGT Not obtained Not performed MGT/MGT
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Table 1 (continued )
Ref. Age/
sex
Presenting
symptoms
Side Location Size
(cm)
Biopsy diagnosis Postoperative
histological
diagnosis
Metastasis; site Treatment Clinical
outcome
Classiﬁcation
according
to the WHO
3rd/4th ed.
Cough,
hemoptysis
Upper lobe,
parahilar
Lymph node, GI
tract, Spleen,
Adrenal gland
DOD within a
few months
[34] 49/M Cough,
dyspnea, chest
pain
R Lower lobe 3.0 Not performed GTUMP No Wedge resection N/A MGT/GTUMP
[35] 59/F Cough,
hemoptysis
L&R Multiple 2.5 MGT Not obtained Lymph node,
Lung, GI tract,
Spleen
Not performed DOD within 20
weeks
MGT/MGT
[36] 66/F ASX R Middle lobe 4.5 Not performed MGT No Lobectomy FOD at 13
months
MGT/
Suspicion of
GTUMP
* 38/F Fever L Lower lobe, B6 2.6 GT GTUMP No Segmentectomy FOD at 24
months
MGT/GTUMP
AWD, alive with disease; ASX, asymptomatic; DOD, died of disease, DOOD, died of other disease; F, female; FOD, free of disease; GI, gastrointestinal; GT, glomus tumor;
GTUMP, glomus tumor of uncertain malignant potential; L, left; M, male; MGT, malignant glomus tumor; N/A, not available; N/D, not determinable because of undetailed
histological information; R, right; *, our case.
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however, the most important differential diagnosis would be a
carcinoid tumor from the viewpoint of pathologists. A considerable
number of primary pulmonary glomus tumors were initially mis-
diagnosed as carcinoid tumors based on the preoperative biopsy or
intraoperative frozen section examinations [10,12,18,21,27,28].
Carcinoid tumors bear some clinical, radiological, and histopatho-
logical similarities to glomus tumors [15]. On the basis of radio-
logical ﬁndings alone, they are difﬁcult to distinguish because both
of them appear as a well-delineated round mass by contrast
enhancement [16]. Histologically, uniformly monotonous tumor
cells having bland round nuclei are common features of both, but
the appearance of tumor cell nuclei is different between the two
tumor entities. Glomus tumors lack the characteristic salt and
pepper appearance of nuclear chromatin distribution typical for
carcinoid tumors. Although both glomus tumors and carcinoid tu-
mors are rich in blood vessels, it is important to note the differences
in vasculature between these tumors. In carcinoid tumors, capil-
laries within delicate ﬁbrous septa separate each tumor cell nest
showing an organoid arrangement typical to neuroendocrine tu-
mors; conversely, glomus tumor cells are constituents of neoplastic
vascular walls resembling a normal glomus body. Immunohis-
tochemically, positivity for cytoplasmic smooth muscle markers
and pericellular basement membrane constituents is a reliable
marker for glomus tumors. Neuroendocrine markers are always
positive in carcinoid tumors, whereas they are negative in glomus
tumors. Thus, immunohistochemical examination deﬁnitively dif-
ferentiates these two entities, and recognition of the aforemen-
tioned cytological and vascular structural features is the most
important point for planning an immunohistochemical evaluation.
Estimation of the malignant potential of bronchopulmonary
glomus tumors is the other problem to be addressed. Indeed, most
glomus tumors are benign and can be treated adequately by simple
excision. However, glomus tumors showing histological atypia have
been recognized, and furthermore, fatal cases with distant metas-
tases are occasionally reported, comprising less than 1% of all
glomus tumors [3]. For primary bronchopulmonary glomus tumors,
10 cases with malignancy have been previously reported
[5,10,13,26,30,32,33,35,36]. Criteria for the diagnosis of malignancy
in glomus tumors was proposed by Folpe et al. for the ﬁrst time in
2001 [5]. The criteria were introduced in a textbook of soft tissue
tumors by Enzinger and Weiss [1] and employed in the WHO
classiﬁcation of soft tissue and bone tumors, 3rd edition [3]. In thecriteria, the diagnosis of “malignant glomus tumor” should be
reserved for tumors showing the following: 1) large size (>2 cm)
and deep location; 2) atypical mitotic ﬁgures; or 3) marked atypia
with mitotic activity. According to the criteria, the majority of
visceral glomus tumors could be diagnosed as “malignant” because
of their consistent “deep” location and relatively large sizes. In the
literature, however,10 out of 19 cases of bronchopulmonary glomus
tumors with sizes of >2.0 cm did not show histologically atypical
features or clinically malignant behavior. Because the ﬁrst criterion
was elaborated mainly based on a large number of atypical glomus
tumors of the skin, whether this criterionwas applicable to visceral
glomus tumors remained uncertain [14]. Currently, growing evi-
dence has shown that most of the large and deeply located glomus
tumors behave in a clinically benign fashion; therefore, the ﬁrst
diagnostic criterion was modiﬁed, and these lesions are now
considered glomus tumors of uncertain malignant potential [2,4].
Previous and current diagnostic criteria of glomus tumors with
atypical features proposed by Folpe et al. are comparatively shown
in Tables 2 and 3. Brieﬂy, glomus tumors of >2 cm in size with a
deep location were previously diagnosed as malignant but are now
categorized as having uncertain malignant potential. Visceral
glomus tumors are essentially considered bearing uncertain ma-
lignant potential because of their deep location. However, malig-
nancies are deﬁned solely by histological ﬁndings in the current
criteria. In our case, the tumor is 2.6 cm in maximal diameter, but
neither mitotic ﬁgures nor an obvious nuclear atypia was observed.
Our case is therefore deﬁned as a glomus tumor of uncertain ma-
lignant potential, according to the current diagnostic criteria [2,4].
The tumor grew cylindrically in the bronchial lumen with no
inﬁltrative growth. There was no necrosis. Ki-67 immunolabeling
was found in only approximately 3% of tumor cells. All of these
ﬁndings suggested the probable benign nature of the tumor. A
conservative surgery was therefore considered feasible. Our
repeated bronchoscopic intervention allowed us to identify the
origin of the tumor, thus opening a door for limited resection.
Without the repeated interventions, the patient would have
required at least a lobectomy. To date, the follow-up of glomus
tumors of uncertain malignant potential has been good, but the
number of cases is small and the follow-up period is short. Because
it is still unclear whether large visceral glomus tumors are truly
benign or potentially malignant indolent tumors, close post-
operative follow-up is warranted.
This research did not receive any speciﬁc grant from funding
Table 2
WHO classiﬁcation of glomus tumors with atypical features.
WHO 3rd edition (2002) WHO 4th edition (2013)
Malignant glomus tumors
1) Size >2 cm and subfascial or visceral location or
2) Marked nuclear atypia and any level of mitotic activity or
3) Atypical mitotic ﬁgures
1) Marked nuclear atypia and any level of mitotic activity or
2) Atypical mitotic ﬁgures
Glomus tumors of uncertain malignant potential
Not fulﬁlling criteria for malignancy, but having at least one atypical feature
other than nuclear pleomorphism
Not fulﬁlling criteria for malignancy, but having at least one atypical feature
other than nuclear pleomorphism
Symplastic glomus tumors
Striking nuclear atypia in the absence of any other worrisome feature (e.g., large
size, deep location, mitotic activity, necrosis)
Striking nuclear atypia in the absence of any other features indicative of
negative outcome (e.g., large size, deep location, mitotic activity, necrosis)
Table 3
Classiﬁcation of glomus tumors with atypical features in Enzinger and Weiss's Soft Tissue Tumors.
5th edition (2008) 6th edition (2014)
Malignant glomus tumors
1) Marked atypia þ mitotic activity (5 > 50 HPF) or
2) Atypical mitotic ﬁgures or
3) Large size (>2 cm) þ deep location
1) Marked atypia þ mitotic activity (5 > 50 HPF) or
2) Atypical mitotic ﬁgures
Glomus tumors of uncertain malignant potential
1) Superﬁcial location þ high mitotic activity (>5/50 HPF) or
2) Large size only or
3) Deep location only
1) Superﬁcial location þ mitotic activity (5 > 50 HPF) or
2) Large size (>2 cm) and/or deep location
Symplastic glomus tumors
Lacks criteria for malignant glomus tumor and marked nuclear atypia only Lacks criteria for malignant glomus tumor and marked nuclear atypia only
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